Stockreport

Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update

Opus Genetics, Inc.  (IRD) 
PDF - Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal experts with additional data expected mid-year 2 [Read more]